Citius Oncology Growth Metrics (2022-2025) | CTOR

Growth Metrics Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 53,838.68%18,492.34%6.50%-29.26%-29.57%76.74%24.59%87.84%86.42%19.64%21.54%
Assets Growth (3y) (Quarter) 794.50%632.58%17.27%
Assets (QoQ) (Quarter) 26,459.57%0.92%1.50%-31.66%52.14%-32.97%1.06%71.50%7.25%1.06%0.29%10.07%8.95%
Cash & Equivalents Growth (1y) (Quarter) -99.93%-99.58%-57.09%3,504,282.14%6,513,695.54%
Cash & Equivalents Growth (3y) (Quarter) 193.29%
Cash & Equivalents (QoQ) (Quarter) -58.37%207.45%-92.83%-57.09%0.00%0.00%0.00%3,504,282.14%85.88%
Cash from Investing Activities (QoQ) (Quarter) -99.72%
Cash from Operations Growth (1y) (Quarter) -13.56%-265.17%
Cash from Operations (QoQ) (Quarter) 40.61%-281.55%-90.99%
EBIT Growth (1y) (Quarter) -81.47%-2,219.60%-39.52%-2,683.35%-6.83%17.87%
EBIT (QoQ) (Quarter) -34.90%-111.20%-987.52%94.14%-1,624.42%-16.83%33.81%4.72%-11.48%
EBT Growth (1y) (Quarter) -3,071.64%-2,219.60%-39.52%-59.25%-10.30%17.59%
EBT (QoQ) (Quarter) -34.90%-111.20%-987.52%-2.36%1.34%-16.83%31.66%7.31%-11.36%
Enterprise Value Growth (1y) (Quarter) 99.93%99.58%57.09%-3,504,282.14%-6,513,695.54%
Enterprise Value Growth (3y) (Quarter) -193.29%
Enterprise Value (QoQ) (Quarter) 58.37%-207.45%92.83%57.09%0.00%0.00%0.00%-3,504,282.14%-85.88%
EPS (Basic) Growth (1y) (Quarter) -200.00%-200.00%-28.57%-57.14%-14.29%33.33%
EPS (Basic) (QoQ) (Quarter) 0.00%-71.43%-450.00%0.00%0.00%-22.22%27.27%25.00%0.00%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -200.00%-200.00%-28.57%-57.14%-14.29%33.33%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) 0.00%-71.43%-450.00%0.00%0.00%-22.22%27.27%25.00%0.00%
Free Cash Flow Growth (1y) (Quarter) -13.56%-265.17%
Free Cash Flow (QoQ) (Quarter) 40.61%-281.55%-90.99%
Interest Coverage Ratio (QoQ) (Quarter) -167.41%-39.29%
Net Cash Flow Growth (1y) (Quarter) 100.35%67.02%
Net Cash Flow (QoQ) (Quarter) 40.61%-161.98%-5,762.50%
Net Income Growth (1y) (Quarter) -3,168.98%-2,291.76%-40.86%-59.97%-12.51%16.90%
Net Income (QoQ) (Quarter) -34.90%-111.20%-1,021.69%-2.29%1.30%-16.16%30.58%6.95%-10.76%
Net Income towards Common Stockholders Growth (1y) (Quarter) -3,168.98%-2,291.76%-40.86%-59.97%-12.51%16.90%
Net Income towards Common Stockholders (QoQ) (Quarter) -34.90%-111.20%-1,021.69%-2.29%1.30%-16.16%30.58%6.95%-10.76%
Operating Income Growth (1y) (Quarter) -81.47%-2,219.60%-6.83%17.87%
Operating Income (QoQ) (Quarter) -34.90%-111.20%-1,624.42%4.72%-11.48%
Profit After Tax Growth (1y) (Quarter) -890.48%-874.44%-40.86%-59.97%-12.51%16.90%
Profit After Tax (QoQ) (Quarter) 0.75%-74.37%-3,093.11%-2.29%1.30%-16.16%30.58%6.95%-10.76%
Return on Assets Growth (1y) (Quarter) 0.000.000.000.000.000.000.000.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -2685.00-3606.00-3916.00-78.00
Return on Capital Employed (QoQ) (Quarter) -26.00-1213.00-946.00-1523.001,053.001,338.00
Return on Equity Growth (1y) (Quarter) 0.003.000.000.000.000.000.000.00
Return on Equity (QoQ) (Quarter) -3.003.000.000.000.000.000.000.000.000.000.00
Return on Invested Capital Growth (1y) (Quarter) 0.00
Return on Invested Capital (QoQ) (Quarter) 0.000.000.000.00
Share-based Compensation Growth (1y) (Quarter) -5.66%-46.09%8.60%118.75%
Share-based Compensation (QoQ) (Quarter) 102.09%-49.48%15.49%1.76%-1.45%88.89%
Shareholder's Equity Growth (1y) (Quarter) 3,516.47%-29.59%6,477.35%9,944.59%865,489.28%80.69%81.69%79.59%90.23%-2.76%41.47%
Shareholder's Equity Growth (3y) (Quarter) 1,498.54%7.35%452.95%
Shareholder's Equity (QoQ) (Quarter) -99.05%-42.81%-101.00%1,297,643.70%-11.01%-12.67%-14.19%170.92%-10.51%-13.68%-9.10%38.48%30.20%
Tax Rate Growth (1y) (Quarter) -99.00-47.00-206.00-88.00
Tax Rate (QoQ) (Quarter) 7.00-4.0060.00-164.00-41.0057.00